Clinical trial
Prophylactic Antibiotics in Measles
NCT00168532 · Bandim Health Project, Other · Completed
Key facts
| NCT number | NCT00168532 |
|---|---|
| Title | Prophylactic Antibiotics in Measles |
| Official title | Prophylactic Antibiotics in Measles Infection. A Community-Based Randomised Double-Blind Placebo-Controlled Trial in Guinea-Bissau |
| Lead sponsor | Bandim Health Project, Other |
| Collaborators | Medical Research Council Unit, The Gambia |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Post-Measles Pneumonia, Measles |
| Intervention type | Drug |
| Interventions | Sulfamethoxazole-Trimethoprim |
| Enrollment | 218 |
| Start date | Jan 1, 1998 |
| Primary completion | Oct 1, 2001 |
| Completion | Oct 1, 2001 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 26, 2008 |
| Countries | Guinea-Bissau |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: